Morphine Hcl Elixir



Indications and Reactions:

Role Indications Reactions
Secondary
Pain 27.7%
Product Used For Unknown Indication 24.2%
Neuralgia 9.0%
Ill-defined Disorder 6.3%
Cancer Pain 5.8%
Constipation 4.4%
Drug Use For Unknown Indication 3.5%
Foetal Exposure During Pregnancy 2.4%
Prophylaxis 2.3%
Insomnia 2.1%
Withdrawal Syndrome 1.6%
Depression 1.5%
Non-small Cell Lung Cancer 1.5%
Analgesic Therapy 1.3%
Back Pain 1.3%
Infection 1.1%
Pyrexia 1.1%
Gastric Cancer 1.0%
General Anaesthesia 1.0%
Multiple Myeloma 1.0%
Withdrawal Syndrome 12.2%
Drug Ineffective 8.9%
Drug Rash With Eosinophilia And Systemic Symptoms 7.8%
Somnolence 7.8%
Dizziness 6.7%
Overdose 6.7%
Respiratory Arrest 6.7%
Abortion Spontaneous 5.6%
Delirium 5.6%
Abdominal Distension 3.3%
Anaemia 3.3%
Drug Effect Decreased 3.3%
Drug Interaction 3.3%
Drug Toxicity 3.3%
Vomiting 3.3%
Weight Increased 3.3%
Completed Suicide 2.2%
Death 2.2%
Hydrocephalus 2.2%
Hypoventilation 2.2%
Concomitant
Drug Use For Unknown Indication 16.1%
Prophylaxis 14.3%
Product Used For Unknown Indication 13.3%
Pain 12.1%
Cancer Pain 8.3%
Multiple Myeloma 4.8%
Hiv Infection 4.3%
Constipation 3.5%
Liver Transplant 3.2%
Prostate Cancer Stage Iv 3.1%
Hypertension 3.1%
Nausea 2.3%
Rectal Cancer 1.7%
Premedication 1.7%
Prostate Cancer 1.5%
Insomnia 1.4%
Mycobacterium Avium Complex Infection 1.3%
Sepsis 1.3%
Analgesic Therapy 1.3%
Epidural Anaesthesia 1.3%
Sepsis 9.0%
White Blood Cell Count Decreased 9.0%
Restless Legs Syndrome 8.4%
Pneumonia 6.6%
Vomiting 6.6%
Prostate Cancer 6.0%
Systemic Inflammatory Response Syndrome 6.0%
Myoclonus 5.4%
Septic Shock 4.8%
Cachexia 4.2%
Interstitial Lung Disease 4.2%
Renal Failure 4.2%
Renal Impairment 4.2%
Ileus 3.6%
Ventricular Tachycardia 3.6%
Nausea 3.0%
Platelet Count Decreased 3.0%
Thrombocytopenia 3.0%
White Blood Cell Count Increased 3.0%
Cauda Equina Syndrome 2.4%
Interacting
Pain 47.1%
Neuralgia 35.3%
Diabetic Neuropathy 11.8%
Herpes Zoster 5.9%
Somnolence 36.4%
Drug Interaction 18.2%
Overdose 18.2%
Respiratory Depression 18.2%
Death 9.1%